Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 11
CAR-T za zdravljenje limfomov in njihovi neželeni učinki
Lučka Boltežar, Aljoša Andlovic
Objavljeni strokovni prispevek na konferenci
Oznake: internistična onkologija;CAR-T terapija;kemoterapija;
Leto: 2024 Vir: Onkološki inštitut Ljubljana (OI)
Granulomatosis after autologous stem cell transplantation in nonHodgkin lymphoma
Lučka Boltežar, Ivana Žagar, Barbara Jezeršek Novaković
Pregledni znanstveni članek
Oznake: granulomatosis;nonHodgin lymphoma;PET-CT;differential diagnosis;
Sarcoidosis before and after treatment of malignancy is an important differential diagnosis that has to be distinguished from lymphoma. Patients and methods. Hodgkin lymphoma, diffuse large B-cell lymphoma and aggressive follicular lymphoma are being staged and treatment effect is evaluated with PET ...
Leto: 2016 Vir: Onkološki inštitut Ljubljana (OI)
Trends in specialized palliative care referrals at an oncology center from 2007 to 2019
Lučka Boltežar, Barbara Jezeršek Novaković, Maja Ebert Moltara
Izvirni znanstveni članek
Oznake: paliativna oskrba;primarni rak;zgodnje napotitve;palliative care;primary site of cancer;early referral;
Leto: 2021 Vir: Onkološki inštitut Ljubljana (OI)
Correlation of t(14;18) translocation breakpoint site with clinical characteristics in follicular lymphoma
Matej Panjan, Lučka Boltežar, Srdjan Novaković, Ira Koković, Barbara Jezeršek Novaković
Izvirni znanstveni članek
Oznake: klinične značilnosti;folikularni limfom;translokacija t(14;18);clinical characteristics;follicular lymphoma;t(14;18) translocation;
Background: t(14;18)(q32;q21) translocation is an important genetic feature of follicular lymphoma resulting in antiapoptotic B-cell lymphoma 2 (BCL2) protein overexpression. On chromosome 18 breakpoint-site variation is high but does not affect BCL2. Breakpoint most commonly occurs at major breakpo ...
Leto: 2023 Vir: Onkološki inštitut Ljubljana (OI)
Ali visoko maligni B-celični limfomi, dvojni ekspresorji, res potrebujejo intenzivnejšo kemoterapijo
Lučka Boltežar, Samo Rožman, Gorana Gašljević, Biljana Grčar-Kuzmanov, Barbara Jezeršek Novaković
Objavljeni znanstveni prispevek na konferenci
Oznake: limfomi;kemoterapija;onkološko zdravljenje;
Velikocelični B limfomi z BCL2 in BCL6 preureditvijo so imenovani "double-hit" oziroma "triplehit" limfomi, z imunohistokemično ekspresijo pa dvojni ekspresorji (DE) in vsi imajo slabšo prognozo od klasičnih velikoceličnih limfomov B. Opravljena je bila študija vseh bolnikov z visoko malignimi B lim ...
Leto: 2023 Vir: Onkološki inštitut Ljubljana (OI)
Do double-expressor high-grade B-cell lymphomas really need intensified treatment
Lučka Boltežar, Samo Rožman, Gorana Gašljević, Biljana Grčar-Kuzmanov, Barbara Jezeršek Novaković
Izvirni znanstveni članek
Oznake: limfomi;dvojno izražen limfom;onkologija;lymphoma;double-expressor lymphoma;oncology;
High-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements are known for their aggressive clinical course and so are the ones with MYC and BCL2 protein overexpression. The optimal therapy for these lymphomas remains to be elucidated. A retrospective analysis of all diffuse large B-cell ...
Leto: 2024 Vir: Onkološki inštitut Ljubljana (OI)
Long-term outcomes of high dose treatment and autologous stem cell transplantation in follicular and mantle cell lymphomas
Lučka Boltežar, Karlo Pintarić, Jože Pretnar, Maja Pohar Perme, Barbara Jezeršek Novaković
Izvirni znanstveni članek
Oznake: follicular lymphoma;mantle cell lymphoma;autologous stem cell transplantation;
Background. Advanced follicular lymphoma (FL) and mantle cell lymphoma (MCL) are incurable diseases with conventional treatment. The high dose treatment (HDT) with autologous stem cell transplantation (ASCT), however, offers a certain proportion of these patients the prospect of a prolonged disease- ...
Leto: 2017 Vir: Onkološki inštitut Ljubljana (OI)
Napovedni in prediktivni dejavniki pri difuznem velikoceličnem limfomu B
Lučka Boltežar, Barbara Jezeršek Novaković, Veronika Kloboves-Prevodnik, Samo Zver, Metka Volavšek, Lorna Zadravec-Zaletel
Doktorska disertacija
Oznake: limfom;difuzni velikocelični limfom B;napovedni dejavniki;prediktivni dejavniki;doktorske naloge;
Napovedni in prediktivni dejavniki pri difuznem velikoceličnem limfomu B
Leto: 2018 Vir: Repozitorij Univerze v Ljubljani (RUL)
CD56-positive diffuse large B-cell lymphoma
Gorana Gašljević, Lučka Boltežar, Srdjan Novaković, Vita Šetrajčič Dragoš, Barbara Jezeršek Novaković, Veronika Kloboves-Prevodnik
Izvirni znanstveni članek
Oznake: difuzni velikocelični limfom;imunohistokemija;limfomi;CD56;diffuse large B-cell lymphoma;immunohistochemistry;lymphomas;
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma. The expression of CD56 in DLBCL is highly unusual. Little is known about its incidence and clinical importance. So far, no genetic profiling was performed in CD56 positive DLBCL.Patients and methods. Tissue microarrays ha ...
Leto: 2023 Vir: Onkološki inštitut Ljubljana (OI)
Priporočila za obravnavo bolnikov z malignimi limfomi
Barbara Jezeršek Novaković, Lučka Boltežar, Andreja Eberl, Gorana Gašljević, Biljana Grčar-Kuzmanov, Monika Jagodic, Barbara Jezeršek Novaković, Tanja Južnič Šetina, Veronika Kloboves-Prevodnik, Gregor Kos, Aleš Christian Mihelač, Milica Miljković, Urška Rugelj, Marija Skoblar Vidmar, Uroš Smrdel, Danijela Štrbac, Miha Toplak, Lorna Zadravec-Zaletel
Strokovna monografija
Oznake: maligni limfomi;smernice;novotvorbe;
Priporočila za obravnavo bolnikov z malignimi limfomi
Leto: 2023 Vir: Onkološki inštitut Ljubljana (OI)
Št. zadetkov: 11
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: